This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Early autism screening has limited effect Screening for autism at three years of age only identifies those ... (18 Jun 2019)
Research explores the impact of masculine ... Pressures and expectations of masculinity and a lack of ... (18 Jun 2019)
Schizophrenia: adolescence is the ... Schizophrenia causes hallucinations and memory or cognition ... (18 Jun 2019)
Atrial fibrillation linked to increased risk ... Atrial fibrillation (AF) is linked to an increased risk of ... (18 Jun 2019)
Study challenges “no pain no gain” ... Patients with peripheral arterial disease should be given the ... (18 Jun 2019)
Saturday, 21 April 2018 09:40

Are antidepressants safe in patients with coronary heart disease? Featured

Rate this item
(0 votes)

An investigation published in the current issue of Psychotherapy and Psychosomatics explores the cardiac events that may occur with the use of antidepressant drugs in coronary artery disease.

The aim of this study was assessing the use of antidepressants by class in relation to cardiology practice recommendations, and the association of antidepressant use with the occurrence of major adverse cardiovascular events including death.

This is a historical cohort study of all patients who completed cardiac rehabilitation between 2002 and 2012 in a major CR center. Participants completed the Patient Health Questionnaire (PHQ-9) at the start and end of the program. A linkage system enabled ascertainment of antidepressant use and MACE through 2014. Of the 1,694 CR participants, 1,266 (74.7%) completed the PHQ-9 after the program. Depressive symptoms decreased significantly from pre- to post-program (p < 0.001). Overall, 433 (34.2%) participants were on antidepressants, most often selective serotonin reuptake inhibitors (SSRI; n = 299; 23.6%). The proportion of days covered was approximately 70% for all 4 major antidepressant classes; discontinuation rates ranged from 37.3% for tricyclics to 53.2% for serotonin-norepinephrine reuptake inhibitors (SNRI). Antidepressant use was significantly associated with lower depressive symptoms after cardiac rehabilitation (p < 0.001). After a median follow-up of 4.7 years, 264 (20.9%) participants had a major adverse cardiovascular event. After propensity matching based on pre- cardiac rehabilitation depressive symptoms among other variables, participants taking tricyclics had significantly more major adverse cardiovascular events than those not taking tricyclics, as well as those taking atypicals versus not and those on SSRI. There was no increased risk with use of SNRI.

These findings suggest that the use of antidepressants was associated with lower depression, but the use of all antidepressants except SNRI was associated with more adverse cardiovascular events.


Source: Journal of Psychotherapy and Psychosomatics
Full bibliographic information
Antidepressant Use by Class: Association with Major Adverse Cardiac Events in Patients with Coronary Artery Disease. Psychother Psychosom 2018;87:85–94

Read 1064 times Last modified on Saturday, 21 April 2018 10:57

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…